![Nisha Nanda](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profil
Nisha Nanda's former job positions include Senior Director-Clinical Science at Onyx Pharmaceuticals, Inc. from 2012 to 2014, Chief Development Officer at Loxo Oncology, Inc. from 2019 to 2023, and Independent Director at Morphic Holding, Inc. from 2021 to 2024.
Dr. Nanda obtained undergraduate and doctorate degrees from The University of New South Wales.
Anciens postes connus de Nisha Nanda
| Sociétés | Poste | Fin |
|---|---|---|
| MORC HOLD | Directeur/Membre du Conseil | 16/08/2024 |
| LOXO ONCOLOGY INC | Corporate Officer/Principal | 01/05/2023 |
Onyx Pharmaceuticals, Inc.
 Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that provide therapeutics for cancer | Corporate Officer/Principal | 01/02/2014 |
Formation de Nisha Nanda
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
40
Relations au 1er degré
4
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that provide therapeutics for cancer | Health Technology |
The University of New South Wales
 The University of New South Wales Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Loxo Oncology, Inc.
 Loxo Oncology, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops medicine for cancer treatment | Health Technology |
Morphic Holding, Inc.
 Morphic Holding, Inc. Pharmaceuticals: MajorHealth Technology Develops oral integrin drugs | Health Technology |
